Jessie Villanueva

Chemically Linked Vemurafenib Inhibitors Promote an Inactive BRAFV600E Conformation.

Ronen Marmorstein, Michael Grasso, J. Maksimoska, 2016, ACS chemical biology.

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K.

Damien Kee, Xiaowei Xu, Meenhard Herlyn, 2010, Cancer cell.

Resistance to BRAF inhibitors: unraveling mechanisms and future treatment options.

Meenhard Herlyn, M. Herlyn, A. Vultur, 2011, Cancer research.

Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma

Zhi Wei, Yiling Lu, Gordon B Mills, 2018, EMBO molecular medicine.